Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes

Saad, E., Saliby, R. M., Labaki, C., Xu, W., Viswanathan, S. R., Braun, D. A., & Bakouny, Z. (2023, October 1). Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes. Hematology/Oncology Clinics of North America. W.B. Saunders. https://doi.org/10.1016/j.hoc.2023.05.023